5 completed. 2 Phase 1, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Hepatic Ascites: new trials by email Literature Review of Hepatic Ascites trials Research Report on Hepatic Ascites
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Recombinant Human Albumin Injection to Treat Hypoalbuminemia in Cirrhotic Patients With Ascites Recombinant Human Albumin Injection, Human Albumin - Hepatic Ascites | Phase 3 | Completed | Tonghua Anrate Biopharmaceutical Co., Ltd. | 416 | 2023-06-16 | 2025-04-04 |
| Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects Recombinant Human Serum Albumin, Human serum albumin - Hepatic Ascites | Phase 1 | Completed | Beijing Protgen Biotechnology Development Co., Ltd. | 36 | 2021-10-14 | 2026-03-11 |
| Phase II/III of Recombinant Human Albumin Injection Recombinant Human Albumin Injection, Human Albumin - Hepatic Ascites | Phase 2 | Completed | The First Hospital of Jilin University | 90 | 2021-09-07 | 2024-05-13 |
| Recombinant Human Serum Albumin in Healthy Subjects recombinant human serum albumin, Human serum albumin - Hepatic Ascites | Phase 1 | Completed | Beijing Protgen Biotechnology Development Co., Ltd. | 48 | 2021-03-29 | 2026-03-11 |
| Effects of Adding Hypertonic Saline Solutions and/or Etilefrine to Standard Diuretics Therapy in Hepatic Ascites Oral standard diuretics therapy, Hypertonic saline solution, Etilefrine - Hepatic Ascites | Phase 2 | Completed | Hala Abd EL-Tawab Ibrahim Radwan | 90 | 2017-11-30 | 2021-03-08 |
Ascites (1)
Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Serum Albumin, Human (4) · recombinant human serum albumin-heme (2) · Etilefrine (1) · Furosemide (1) · Saline Solution, Hypertonic (1) · Sodium Chloride (1) · Spironolactone (1)
Beijing Protgen Biotechnology Development Co., Ltd. (2) · Hala Abd EL-Tawab Ibrahim Radwan (1) · The First Hospital of Jilin University (1) · Tonghua Anrate Biopharmaceutical Co., Ltd. (1)
China (4) · Egypt (1)
Bei Hu, Ph.D (1) · Gamal A Badra, professor (1) · Junqi Junqi (1) · Rui Chen, Ph.D (1) · Sahar El-Haggar, professor (1)
PMID 11232182, PMID 12660656, PMID 15196097, PMID 16474108, PMID 17172977, PMID 19602136, PMID 20346637, PMID 21749847, PMID 22844565, PMID 24462960, PMID 24811138, PMID 24829672, PMID 26630543, PMID 27941973, PMID 27991854, PMID 28285098, PMID 28661458, PMID 28932357, PMID 29608812, PMID 30992841, PMID 3522371, PMID 680588